MEDACTA GROUP S.A. SF-,10/ CH0468525222 /
- - | Var. - | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
-EUR | - | 0 Fatturato: 0.00 |
-Quantità in denaro: - | -Quantità in lettera: - | 2.58 bill.EUR | 0.44% | 54.53 |
Newsfile Corp
03:22
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Endava
Newsfile Corp
02:03
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before I...
Newsfile Corp
01:07
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Impor...
Newsfile Corp
01:04
CXM DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sprinklr, Inc. Investors with Losses in E...
Newsfile Corp
00:43
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Iris Energy Limited Investors to Secure Counsel Before ...
Newsfile Corp
00:36
SEE Shines at New York Climate Week, Highlighting Progressive Climate Solutions In China
Newsfile Corp
00:27
ROSEN, A TOP RANKED LAW FIRM, Encourages Domino's Pizza, Inc. Investors to Secure Counsel Before Imp...
Newsfile Corp
00:16
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Be...
Newsfile Corp
00:14
ARDX DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secur...